Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

ROCKET PHARMACEUTICALS, INC.

RCKT · Nasdaq · CIK 0001281895 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

24 Form 4 transaction lines observed in the same window
15 sales · 9 option, withholding, award, gift or other lines

Last qualifying purchase2026-01-02 · Bjork Elisabeth · $34.4K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Shah GauravCEO
▼▼○▼▼▼
Wilson MartinGeneral Counsel
▼▼▼▼▼
Militello JohnSee Remarks
▼▼
Chaudhuri SarbaniSee Remarks
▼▼
Stevens Christopher JamesChief Operating Officer
○▼
SOUTHWELL DAVID PDirector
○○
● Purchase▼ Sale○ Other

Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-01-02 · Bjork Elisabeth.

Recent Form 4 activity

1Purchases
25Sales
16Other Form 4 lines
41SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING15 sale line(s) · context only
OTHER9 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
15,049,780
Previous report
14,847,478
Avg daily volume
2,169,320
Days to cover
6.9

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-01-02Bjork ElisabethPurchase (P)Common Stock10,000USD 3.44USD 34,400SEC filing ↗
2025-08-27Bjork ElisabethPurchase (P)Common Stock10,000USD 3.41USD 34,100SEC filing ↗
2025-04-10Shah GauravPurchase (P)Common Stock20,000USD 5.08USD 101,600SEC filing ↗
2025-04-09Patel KinnariPurchase (P)Common Stock21,099USD 4.70USD 99,165SEC filing ↗
2022-10-06RTW INVESTMENTS, LP; WONG RODERICKPurchase (P)Common Stock, $0.01 par value ("Common Stock")1,355,932USD 14.75USD 19,999,997SEC filing ↗
2022-02-07Shah GauravPurchase (P)Common Stock22,000USD 17.34USD 381,480SEC filing ↗
2020-12-10RTW INVESTMENTS, LP; WONG RODERICK; Yalamanchi NaveenPurchase (P)Common Stock247,720USD 56.00USD 13,872,320SEC filing ↗
2020-03-18Patel KinnariPurchase (P)Common Stock1,000USD 9.50USD 9,500SEC filing ↗

Form 4 evidence

42 transaction lines in the latest 365-day window; 259 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-11Wilson MartinSale (S)Common Stock75,364USD 3.40USD 256,238SEC filing ↗
2026-08-18Wilson MartinSale (S)Common Stock631USD 3.38USD 2,133SEC filing ↗
2026-08-18Shah GauravSale (S)Common Stock2,293USD 3.38USD 7,750SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-11Wilson MartinSale (S)Common Stock75,364USD 3.40USD 256,238SEC filing ↗
2026-08-18Wilson MartinSale (S)Common Stock631USD 3.38USD 2,133SEC filing ↗
2026-08-18Shah GauravSale (S)Common Stock2,293USD 3.38USD 7,750SEC filing ↗
2026-08-13Wilson MartinSale (S)Common Stock3,493USD 3.38USD 11,806SEC filing ↗
2026-08-13Shah GauravSale (S)Common Stock2,837USD 3.38USD 9,589SEC filing ↗
2026-08-11Stevens Christopher JamesSale (S)Common Stock36,658USD 3.50USD 128,303SEC filing ↗
2026-08-11Chaudhuri SarbaniSale (S)Common Stock4,701USD 3.50USD 16,454SEC filing ↗
2026-08-03Stevens Christopher JamesAward / grant (A)Common Stock73,313USD 0.00USD 0SEC filing ↗
2026-08-03SOUTHWELL DAVID PJ (J)Common Stock150,000USD 0.00USD 0SEC filing ↗
2026-06-18WONG RODERICKAward / grant (A)Common Stock27,832USD 0.00USD 0SEC filing ↗
2026-06-18SOUTHWELL DAVID PAward / grant (A)Common Stock22,862USD 0.00USD 0SEC filing ↗
2026-06-18Malik Fady IbrahamAward / grant (A)Common Stock22,862USD 0.00USD 0SEC filing ↗
2026-06-18Fong PeterAward / grant (A)Common Stock22,862USD 0.00USD 0SEC filing ↗
2026-06-18Dolsten MikaelAward / grant (A)Common Stock22,862USD 0.00USD 0SEC filing ↗
2026-06-18BOESS CARSTENAward / grant (A)Common Stock22,862USD 0.00USD 0SEC filing ↗
2026-05-21Shah GauravSale (S)Common Stock55,684USD 3.09USD 172,064SEC filing ↗
2026-05-21Shah GauravOption exercise / conversion (M)Common Stock76,490USD 1.69USD 129,268SEC filing ↗
2026-05-19Wilson MartinSale (S)Common Stock662USD 3.01USD 1,993SEC filing ↗
2026-05-19Shah GauravSale (S)Common Stock2,409USD 3.01USD 7,251SEC filing ↗
2026-05-19Militello JohnSale (S)Common Stock384USD 3.01USD 1,156SEC filing ↗
2026-05-13Wilson MartinSale (S)Common Stock3,361USD 3.61USD 12,133SEC filing ↗
2026-05-13Shah GauravSale (S)Common Stock2,728USD 3.61USD 9,848SEC filing ↗
2026-05-13Militello JohnSale (S)Common Stock855USD 3.61USD 3,087SEC filing ↗
2026-05-07Chaudhuri SarbaniSale (S)Common Stock17,650USD 3.84USD 67,776SEC filing ↗
2026-02-18Wilson MartinSale (S)Common Stock1,376USD 3.34USD 4,596SEC filing ↗
2026-02-18Shah GauravSale (S)Common Stock5,990USD 3.34USD 20,007SEC filing ↗
2026-02-18Militello JohnSale (S)Common Stock1,157USD 3.34USD 3,864SEC filing ↗
2026-02-13Wilson MartinSale (S)Common Stock12,253USD 3.31USD 40,557SEC filing ↗
2026-02-13Shah GauravSale (S)Common Stock12,279USD 3.31USD 40,643SEC filing ↗
2026-02-13Militello JohnSale (S)Common Stock3,726USD 3.31USD 12,333SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerRCKT
CIK0001281895
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history259 transaction lines from 2020-02-25 to 2026-09-11
8 P purchase lines · 120 S sale lines · 131 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.